Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.7K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

117
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
117
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

839
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
839
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

1.2K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.2K
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

133
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
133
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

1.1K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study.

Frontiers in immunology·2026
Same author

Tuning hyperparameters of doublet-detection methods for single-cell RNA sequencing data.

Quantitative biology (Beijing, China)·2026
Same author

Leveraging large language models for rare disease named entity recognition.

PLOS digital health·2026
Same author

New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study.

bioRxiv : the preprint server for biology·2025
Same author

Synergistic Composite Solid Electrolyte Based on Multifunctional Polymer Networks for High-Performance Lithium Metal Batteries.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Regenerative Signatures in BAL of Acute Respiratory Distress Syndrome.

American journal of respiratory cell and molecular biology·2024

Related Experiment Video

Updated: Sep 6, 2025

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

3.9K

Statistical learning in preclinical drug proarrhythmic assessment.

Nan Miles Xi1, Yu-Yi Hsu2, Qianyu Dang2

  • 1Department of Mathematics and Statistics, Loyola University Chicago, Chicago, Illinois, USA.

Journal of Biopharmaceutical Statistics
|June 30, 2022
PubMed
Summary

Predicting drug-induced Torsades de pointes (TdP) risk is crucial for patient safety. New statistical models accurately assess low-, intermediate-, and high-risk drugs from preclinical data, aiding drug safety evaluations.

Keywords:
drug safety assessmentordinal logistic regressionordinal random forestprediction of torsades de pointesstatistical learning

More Related Videos

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K
Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
10:41

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology

Published on: September 13, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 6, 2025

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice
06:07

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

3.9K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K
Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
10:41

Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology

Published on: September 13, 2022

2.2K

Area of Science:

  • Pharmacology and Toxicology
  • Computational Biology
  • Biostatistics

Background:

  • Torsades de pointes (TdP) is a life-threatening arrhythmia linked to drug toxicity.
  • Preclinical studies investigate drug-induced TdP, but robust predictive frameworks are needed.
  • Accurate risk prediction is essential for drug safety assessment.

Purpose of the Study:

  • To develop and validate a statistical learning framework for predicting drug-induced TdP risk.
  • To classify drugs into low-, intermediate-, and high-risk categories using preclinical data.
  • To provide interpretable and accurate tools for drug safety evaluation.

Main Methods:

  • Ordinal logistic regression and ordinal random forest models were employed.
  • Datasets from two experimental protocols were utilized for model training and testing.
  • Leave-one-drug-out cross-validation, stratified bootstrap, and permutation importance assessed model performance and interpretability.

Main Results:

  • The proposed models accurately predicted drug-induced TdP risk categories.
  • Identified outlier drugs aligned with existing literature, demonstrating model validity.
  • The methods provided accurate and interpretable risk assessments.

Conclusions:

  • Ordinal logistic regression and random forest models offer a reliable approach for predicting drug-induced TdP risk.
  • These models can serve as valuable supplemental evidence in drug safety assessments.
  • The developed framework enhances the understanding and prediction of cardiac arrhythmia risks associated with drug candidates.